Literature DB >> 1333936

Lupus anticoagulant in silica-induced scleroderma.

J M Durand, M F Aillaud, G Kaplanski, P Lefevre, M C Alessi, I Juhan-Vague, J Soubeyrand.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1333936     DOI： 10.1007/bf02207217

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  9 in total

1.  The association: scleroderma-silicosis or Erasmus' syndrome (author's transl).

Authors:  B Devulder; B Plouvier; J C Martin; L Lenoir
Journal:  Nouv Presse Med       Date:  1977-10-01

2.  [Lupus anticoagulant and thromboses in scleroderma].

Authors:  L Guillevin; G Leroux; J Berdah
Journal:  Ann Med Interne (Paris)       Date:  1987

3.  Multiple actions of interleukin 6 within a cytokine network.

Authors:  G G Wong; S C Clark
Journal:  Immunol Today       Date:  1988-05

4.  [Scleroderma and circulating anticoagulant of the antiprothrombinase type].

Authors:  H Saveuse; E Rouveix; J Roussi; M Dorra
Journal:  Ann Med Interne (Paris)       Date:  1988

5.  Activity of a macrophage factor in collagen formation by silica.

Authors:  A G Heppleston; J A Styles
Journal:  Nature       Date:  1967-04-29       Impact factor: 49.962

6.  Circulating anticoagulant in CREST syndrome.

Authors:  J Albert; J M Ekoe; M Cunningham; L Humair
Journal:  Br J Rheumatol       Date:  1984-02

7.  Silica-associated systemic sclerosis is clinically, serologically and immunologically indistinguishable from idiopathic systemic sclerosis.

Authors:  M H Rustin; H A Bull; V Ziegler; J Mehlhorn; U F Haustein; P J Maddison; J James; P M Dowd
Journal:  Br J Dermatol       Date:  1990-12       Impact factor: 9.302

8.  Silica-induced scleroderma.

Authors:  U F Haustein; V Ziegler; K Herrmann; J Mehlhorn; C Schmidt
Journal:  J Am Acad Dermatol       Date:  1990-03       Impact factor: 11.527

9.  Classification of systemic sclerosis (scleroderma): relationship of cutaneous subgroups in early disease to outcome and serologic reactivity.

Authors:  A T Masi
Journal:  J Rheumatol       Date:  1988-06       Impact factor: 4.666
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.